Header

UZH-Logo

Maintenance Infos

Antimetastatic activities of heparins and modified heparins. Experimental evidence


Borsig, L (2010). Antimetastatic activities of heparins and modified heparins. Experimental evidence. Thrombosis Research, 125(Suppl2):S66-S71.

Abstract

Heparin is commonly used for prevention or treatment of cancer-associated thromboembolism. Recent clinical evidence indicates that heparin, and low-molecular weight heparin improves survival of cancer patients. Experimental evidence from various animal models consistently supports the ability of heparin to attenuate metastasis. Heparin, apart from its anticoagulant activity contains a variety of biological activities possibly affecting cancer progression, including: inhibition of heparanase, blocking of P- and L-selectin mediated cell adhesion, and inhibition of angiogenesis. The delineation of antimetastatic activity of heparin is in the focus of several ongoing investigations. This review summarizes the current experimental evidence on the biology of heparin as a potential treatment cancer progression.

Abstract

Heparin is commonly used for prevention or treatment of cancer-associated thromboembolism. Recent clinical evidence indicates that heparin, and low-molecular weight heparin improves survival of cancer patients. Experimental evidence from various animal models consistently supports the ability of heparin to attenuate metastasis. Heparin, apart from its anticoagulant activity contains a variety of biological activities possibly affecting cancer progression, including: inhibition of heparanase, blocking of P- and L-selectin mediated cell adhesion, and inhibition of angiogenesis. The delineation of antimetastatic activity of heparin is in the focus of several ongoing investigations. This review summarizes the current experimental evidence on the biology of heparin as a potential treatment cancer progression.

Statistics

Citations

43 citations in Web of Science®
50 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

70 downloads since deposited on 14 Jan 2011
20 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Institute of Physiology
07 Faculty of Science > Institute of Physiology
Dewey Decimal Classification:570 Life sciences; biology
Language:English
Date:15 April 2010
Deposited On:14 Jan 2011 15:32
Last Modified:07 Dec 2017 05:05
Publisher:Elsevier
ISSN:0049-3848
Publisher DOI:https://doi.org/10.1016/S0049-3848(10)70017-7
PubMed ID:20434009

Download

Download PDF  'Antimetastatic activities of heparins and modified heparins. Experimental evidence'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 233kB
View at publisher